Dementia toolkit for clinicians underscores urgency of early diagnosis
By
Alicia Lasek
Mar 31, 2021
A primary care toolkit for brain health assessment and dementia diagnosis has gotten a much-needed update as more research points to the potential for better outcomes with earlier diagnoses, the authors...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...
Nursing home advocates urge 24-hour RN staffing, PPE mandates in sweeping reform agenda
By
Alicia Lasek
Mar 16, 2021
The Care For Our Seniors Act, put forth by the AHCA and LeadingAge, seeks to address systemic issues in the nursing home sector that have been laid bare during the pandemic, including infection control...
U.S., Canada ‘not that different’ in LTC staff response to pandemic work conditions: study
By
Alicia Lasek
Feb 19, 2021
“We talk about how great Canada’s healthcare system is vis-à-vis that of the United States … but we are not that different when it comes to long-term care,” the researchers say.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Face masks an anxiety-provoking obstacle for many with hearing loss, survey finds
By
Alicia Lasek
Feb 03, 2021
Fully 95% of people living with hearing loss in the United States say that masks and face-coverings are creating communication barriers, and more than half say they are experiencing anxiety and isolation...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
CDC’s social media toolkit tackles COVID-19 vaccination education
By
Alicia Lasek
Jan 11, 2021
LTC providers can use a new set of pre-written social media messages and digital images to encourage staff and residents to learn more about COVID-19 vaccine safety and benefits.
Medication may boost thinking speed in advanced multiple sclerosis
By
Alicia Lasek
Dec 21, 2020
People with secondary progressive multiple sclerosis who take the drug siponimod for two years show an improvement in thinking skills, researchers say.